Major project results explained by MICROB-PREDICT's early-career scientists (ECS)

Results Videos

Metagenomics-Metaproteomics Pipeline for Biomarker Discovery in ACLF (Peter Treit)

Peter Treit, a PhD Candidate in Matthias Mann’s group at the Max-Planck Institute of Biochemistry in Munich, Germany, describes the collaborative pan-European data pipeline of the MICROB-PREDICT consortium from bio-sampling to sample analysis (including metagenomics, transcriptomics, and metaproteomics) to assemble a multi-omics biomarker panel for ACLF and to build reliable predictive models for optimal patient stratification and treatment selection. In March 2024, the consortium discussed relevant model parameters at the 6th General Assembly in Ljubljana, Slovenia, models that will be thoroughly tested, benchmarked, and validated before their application in clinical practice.

Multi-omics biomarkers for early identification of Pre-ALCF (Camila Alvarez-Silva)

Camila Alvarez-Silva (PhD), a postdoctoral researcher in the group of Mani Arumugam at the University of Copenhagen, Denmark, presents the approach and first results of a multi-omics study to identify biomarkers for early identification of PreALCF patients. The video was recorded during the 6th MICROB-PREDICT GA Meeting in Ljubljana, Slovenia, and includes the graphical abstract of the study.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 825694. This website reflects only the authors' view and the European Commission is not responsible for any use that may be made of the information it contains.

© MICROB-PREDICT 2024